mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.3 |
mRNA |
CHM-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.3 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.3 |
mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
-0.029 |
0.3 |
mRNA |
Tamoxifen |
GDSC1000 |
pan-cancer |
AAC |
-0.032 |
0.3 |
mRNA |
B02 |
CTRPv2 |
pan-cancer |
AAC |
0.037 |
0.3 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |
mRNA |
BRD-K09344309 |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.4 |
mRNA |
MI-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.4 |
mRNA |
STF-62247 |
GDSC1000 |
pan-cancer |
AAC |
0.03 |
0.4 |